|
|
|
BuGuCh & Partnersis a supplier of
|
|
(5S,12S)-Dihydroxy-(6E,8E,10E,14Z)-Eicosatetraenoic acid |
|
|
This listing includes other chemicals and chemical products supplied by BuGuCh & Partners.
Click the line at a product and you will get the email form to send an inquiry.
|
|
|
Product names |
CAS numbers |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Information on BuGuCh & Partners |
We, BuGuCh & Partners, are an international acting and innovative company, leading in developing and manufacturing.
We operates major facilities in North America, Europe and the Pacific Rim, as well as facilities in China, Japan and Saudi Arabia operated through joint ventures.
We maintain independently or are partners of some production sites in Europe, Asia and South America. Our global network is a strength.
Our products range from natural gas, oil and basic chemical products through innovative intermediates to specialties, high value-added chemicals, crop protection products and pharmaceuticals.
|
BuGuCh & Partners also offers: (5S,12R)-Dihydroxy-(6E,8E,10E,14Z)-eicosatetraenoic acid (5S)-N-(5-Amino-1-carboxypentyl)iminodiacetic acid (5S)-4-Acetyl-1-(4-chloro-2-fluorophenyl)-5-cyclohexyl-1,5-dihydro-3-hydroxy-2H-pyrrol-2-one (5S)-3-(3-Fluorophenyl)-5-(hydroxymethyl)-2-oxazolidinone (5S)-3,4,5,6-tetrahydro-5-phenyl-N-(benzyloxycarbonyl)-4(h)-1,4-oxazin-2-one (5S)-3,4,5,6-tetrahydro-5-phenyl-4(h)-1,4-oxazin-2-one (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-yl methyl ester (5R,6S)-5,6-Diphenyl-2-morpholinone (5R,6S)-3-((2-Formimidamidoethyl)thio)-6-((R)-1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid hydrate (5R,2S)-2,5-Diamino adipic acid dihydrochloride (5R,2R)-2,5-Diamino adipic acid dihydrochloride (5R,15S)-Dihydroxy-(6E,8Z,11Z,13E)-Eicosatetraenoic acid (5R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-(hydroxymethyl)-2-oxazolindinone (5R)-3-(3-Fluorophenyl)-5-[[(methylsulfonyl)oxy]methyl]-2-oxazolidinone (5R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)-2-oxazolidinone (5R)-3,4,5,6-tetrahydro-5-phenyl-N-(benzyloxycarbonyl)-4(h)-1,4-oxazin-2-one (5R)-3,4,5,6-tetrahydro-5-phenyl-4(h)-1,4-oxazin-2-one (5Or8)-[[2,4-diamino-5-[(4-sulfophenyl)azo]phenyl]azo]-(8or5)-(phenylazo)naphthalene-2-sulfonic acid (5beta)-3beta-[(6-deoxy-beta-D-glucopyranosyl)oxy]-14-hydroxycard-20(22)-enolide (5beta)-3beta-[(2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide (5beta)-14-Hydroxy-3-oxocard-20(22)-enolide (5As,10bR)-2-mesityl-4,5a,6,10b-tetrahydro-2H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazin-11-ium tetrafluoroborate (5alpha,9alpha,11R*)-dimethyl[5,6,9,10-tetrahydro-5,9-methanobenzocycloocten-11-yl]ammonium chloride (5alpha,8alpha,9alpha)-2-chloro-5,8,9,10-tetrahydro-5,9-methanobenzocycloocten-8-ylammonium chloride (5alpha,8alpha)-6,7-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-8-ol (5alpha,7alpha,8Beta)-(+)-N-methyl-N-(7-[1-pyrrolidinyl]-1-oxaspiro[4.5]dec-8-yl)benzeneacetamide (5alpha,6beta)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (5alpha,6Beta)-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan (5alpha,6alpha)-7,8-didehydro-4,5-epoxymorphinan-3,6-diyl dipropionate (5alpha,6alpha)-7,8-Didehydro-4,5-epoxymorphinan-3,6-diol hydrochloride (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-yl pyridine-3-carboxylate hydrochloride (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-ethoxy-6-hydroxy-17,17-dimethylmorphinanium iodide (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3,6-dihydroxy-17,17-dimethylmorphinanium iodide (5alpha,6alpha)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diyl [r-(r*,r*)]-2,3-dihydroxysuccinate (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-(2-propynyl)morphinan-3,6-diol (5alpha,6alpha)-4,5-Epoxy-3-methoxy-17-methylmorphinan-6-ol hydrochloride (5alpha,6alpha)-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-yl acetate (5alpha,10alpha,12S*)-[10,11-dihydro-5,10-methano-5H-dibenzo[a,d]cycloheptene-12-methyl]dimethylammonium chloride (5alpha,10alpha,12R*)-[10,11-dihydro-5,10-methano-5H-dibenzo[a,d]cycloheptene-12-methyl]dimethylammonium chloride (5alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-one hydrobromide (5alpha)-7,8-didehydro-4,5-epoxy-3,14-dihydroxymorphinan-6-one (5alpha)-7,8-Didehydro-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one (5alpha)-6,7-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-yl acetate hydrochloride (5alpha)-6,7-didehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan (5alpha)-6,7,8,14-tetradehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan hydrochloride (5alpha)-4,5-Epoxy-3,14-dihydroxymorphinan-6-one (5alpha)-4,5-epoxy-14-hydroxy-3-methoxy-17-(2-propynyl)morphinan-6-one (5-[4-[2-[N-Methyl-N-(2-pyridinyl)amino]ethoxy]benzylidene]-2,4-thiazolidinedione (5-Trifluoromethyl-pyridin-3-yl)acetic acid (5-Thien-2-yl-1H-pyrazol-3-yl)methanol
|
|
|
(5S,12S)-Dihydroxy-(6E,8E,10E,14Z)-Eicosatetraenoic acid is offered by other companies |
Leap Chem Co., Ltd
|
Leap Chem Co., Ltd
|
|
|
|
|
|